Tetronal

Tetronal is a sedative and hypnotic drug which is a barbiturate derivative. It was developed by Bayer in the late 19th century and marketed primarily in Europe and the United States. Tetronal is a Schedule III drug under the Convention on Psychotropic Substances. It is also known as tetronal or tetronal barbiturate.

History[edit | edit source]

Tetronal was first synthesized by Adolf von Baeyer in 1864. It was one of the first barbiturates to be developed and was used as a sedative and hypnotic until the mid-20th century. The drug was marketed by Bayer under the brand name "Tetronal".

Pharmacology[edit | edit source]

Tetronal is a barbiturate, a class of drugs that act as central nervous system depressants. Barbiturates work by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity. This results in sedation, hypnosis, and decreased anxiety.

Medical uses[edit | edit source]

Tetronal was used as a sedative and hypnotic in the treatment of insomnia and anxiety disorders. It was also used in the treatment of epilepsy and seizure disorders.

Side effects[edit | edit source]

Common side effects of Tetronal include drowsiness, dizziness, and confusion. More serious side effects can include respiratory depression, addiction, and overdose.

Legal status[edit | edit source]

Tetronal is a Schedule III drug under the Convention on Psychotropic Substances. This means that it has a potential for abuse and dependence, but also has accepted medical uses.

See also[edit | edit source]

Tetronal Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.